Show results for
Refine by
Biomarker Discovery Services Available In Finland
17 services found
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics partners with biopharma companies and Clinical Centers of Excellence to facilitate biomarker discovery programs in support of early discovery, translational, and clinical programs that may have companion diagnostic development needs. ...
by:Indivumed GmbH based inHamburg, GERMANY
Biomarkers are important when it comes to the development of novel drugs and mechanisms and are also gaining importance as companion diagnostic ...
Manufactured by:Creative Biogene-Mitochondrial Research based inNY, NEW YORK (USA)
To further meet the needs of multi-group joint analysis, through the integrated analysis of multi-group data, Creative Biogene provides a systematic and overall solution for global researchers, such as mitochondrial regulation mechanism, disease target screening, biomarker discovery, and so on. We provide new ideas for researchers studying mitochondrial molecular ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Utilizing targeted next-generation sequencing of these variable regions, can provide deeper insights into B-cell differentiation, BCR somatic hypermutation, class switching, and antigen specificity. Major applications of BCR repertoire profiling include diagnostic biomarker discovery, tracking known repertoire sequences and disease diagnosis. ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s Advanced Pathology Services (APS) team provides end-to-end solutions to support translational and clinical research by providing a combination of routine and unique tissue testing services. As part of the REALM IDx, Inc. group, our pathology service laboratories support projects spanning preclinical biomarker discovery research to clinical trials ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Drive biomarker and drug discovery by unlocking novel insights on disease pathophysiology, biomarker expression, and drug response at the tissue and cellular ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Single cell analysis has become a gold standard application in both basic as well as translational research. Several approaches are now available that capture the maximal transcript diversity in a given cell and allowing for multi-model analysis strategies to generate meaningful insights. MedGenome has adopted several commercially available platforms for single cell ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s professional framework for clinical trial assay (CTA) and companion diagnostics (CDx) development allows our clients to confidently advance priority projects. With an end-to-end service infrastructure, we support all aspects of assay development, manufacturing, life cycle management, regulatory submissions, marketing support, and commercialization for our ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Single cell analysis has become a gold standard application in both basic as well as translational research. Several approaches are now available that capture the maximal transcript diversity in a given cell and allowing for multi-model analysis strategies to generate meaningful insights. MedGenome has adopted several commercially available platforms for single cell ...
by:Burning Rock Biotech Limited based inGuangzhou, CHINA
Burning Rock utilizes our own proprietary large-scale genomic dataset based on personalized analyses of Chinese cancer patients*, ntegrates the experience from multi-dimensional clinical/scientific research and published data, to provide a one-stop cancer genomic data solution for biopharma partners, aiming to speed up precision drug development and reduce the risks. Burning Rock provides ...
by:Excelra based inIselin, NEW JERSEY (USA)
As the volume of biomedical data increases, so does the complexity of drug discovery and development programs. There’s a wealth of opportunity out there but capturing high-quality data and putting it to immediate productive use is often expensive and inefficient. We know that data alone can’t provide insight. You need more than just data. You need ...
Manufactured by:Owlstone Medical Ltd. based inCambridge, UNITED KINGDOM
Developing Breath Biopsy for clinical applications in early detection and precision ...
Manufactured by:Firalis Group based inHuningue, FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
by:Cmbio based inCopenhagen, DENMARK
At Cmbio, we offer both shallow and deep shotgun sequencing options to suit the specific requirements of your study. Whether you're conducting exploratory research, clinical trials, or large-scale population studies, our services are designed to deliver accurate, high-quality data that empowers your ...
Manufactured by:Bio-Me based inOslo, NORWAY
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug Developers. Bio-Me’s Precision Microbiome Profiling (PMP™) technology, based on qPCR, is perfectly positioned to support drug developers in their development pipeline and successful market ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...